Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is a vaccine against AIDS possible?

D Langley1, R E Spier

  • 1Department of Microbiology, University of Surrey, Guildford, UK.

Vaccine
|February 1, 1988
PubMed
Summary

Controlling human immunodeficiency viruses (HIV) spread is critical. Antiviral agents targeting HIV replication show promise, but selective drug design is challenging, necessitating exploration of existing medicines and urgent vaccine development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors limiting the commercial application of animal cells in culture.

Cytotechnology·2012
Same author

Japanese association for animal cell technology.

Cytotechnology·2012
Same author

Advances in animal cell biology and technology for bioprocesses.

Cytotechnology·2012
Same author

Some myths and messages concerning the batch and continuous culture of animal cells.

Cytotechnology·2012
Same author

Animal cells in culture are microorganisms.

Cytotechnology·2012
Same author

Letter to the editor.

Cytotechnology·2008

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • The spread of human immunodeficiency viruses (HIV) necessitates effective control strategies.
  • Interference with the HIV replicative cycle is a key area of research.
  • Existing antiviral therapies face challenges in selectivity and side effect profiles.

Purpose of the Study:

  • To review current options for interfering with the HIV replicative cycle.
  • To explore the potential of antiviral agents targeting different stages of HIV replication.
  • To highlight the importance of vaccination as a long-term HIV control strategy.

Main Methods:

  • Review of existing literature on HIV replication and antiviral strategies.
  • Analysis of the challenges in designing selective antiviral agents.
  • Consideration of random screening of existing medicinal compounds.
  • Evaluation of vaccination as an intervention for HIV infection.

Main Results:

  • Antiviral agents can potentially target each stage of the HIV replicative cycle.
  • Designing highly selective antiviral agents free from side effects is difficult.
  • Random screening of existing medicines may yield effective compounds.
  • Vaccination is a crucial strategy requiring urgent and thorough investigation.

Conclusions:

  • Developing effective and safe antiviral therapies for HIV remains a significant challenge.
  • Exploring diverse approaches, including drug repurposing and novel therapeutic strategies, is essential.
  • Vaccination holds significant potential for the long-term control and eradication of HIV infection.

Related Experiment Videos